Financials
- Market Capitalization 215.98 M
- Employee 228
- Founded 2008
- CEO N/A
- Website www.karyopharm.com
- Headquarter Delaware, United States
- FIGI BBG001J272L7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.34
市销率
0
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3577 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.65 USD | -1.08% | -6.89% | -6.41% | +15.14% | 218.56 M USD | ||
| 3579 | KROS Keros Therapeutics, Inc. - common stock | 11.03 USD | +4.35% | -5.32% | +9.32% | -26.95% | 218.30 M USD | ||
| 3586 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 77.22 USD | +2.43% | +2.96% | +8.23% | +809.54% | 215.15 M USD | ||
| 3590 | NBP NovaBridge Biosciences - American Depositary Shares | 1.85 USD | +2.78% | -4.15% | +20.13% | -58.98% | 213.46 M USD |